Form 8-K - Current report:
SEC Accession No. 0001453687-25-000119
Filing Date
2025-11-06
Accepted
2025-11-06 07:03:08
Documents
14
Period of Report
2025-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rnac-20251106.htm   iXBRL 8-K 30881
2 EX-99.1 exhibit991_earningsrelease.htm EX-99.1 120997
6 cartesian_logoxcolorxcmyka.jpg GRAPHIC 1268513
  Complete submission text file 0001453687-25-000119.txt   1956027

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnac-20251106.xsd EX-101.SCH 1862
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnac-20251106_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnac-20251106_pre.xml EX-101.PRE 12572
16 EXTRACTED XBRL INSTANCE DOCUMENT rnac-20251106_htm.xml XML 2722
Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address 7495 NEW HORIZON WAY FREDERICK MD 21703 301-348-8698
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 251456080
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)